Avalon Trust’s Novo Nordisk NVO Stock Holding History

Avalon Trust’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$73.5K	Hold	2,000	–	–	0.01%	244
2025 Q4	$102K	Sell	2,000 -372	-16%	-$19K	0.01%	200
2025 Q3	$132K	Sell	2,372 -639	-21%	-$37.4K	0.01%	194
2025 Q2	$208K	Sell	3,011 -64	-2%	-$4.35K	0.02%	137
2025 Q1	$214K	Buy	3,075 +14	+0.5%	+$1.16K	0.02%	127
2024 Q4	$263K	Buy	3,061 +689	+29%	+$74.5K	0.02%	111
2024 Q3	$282K	Hold	2,372	–	–	0.02%	107
2024 Q2	$339K	Hold	2,372	–	–	0.03%	98
2024 Q1	$305K	Hold	2,372	–	–	0.03%	109
2023 Q4	$245K	Hold	2,372	–	–	0.02%	112
2023 Q3	$216K	Hold	2,372	–	–	0.02%	112
2023 Q2	$192K	Hold	2,372	–	–	0.02%	126
2023 Q1	$189K	Buy	+2,372	New	+$168K	0.02%	122

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Avalon Trust's NVO Position: Q1 2026 in Review

Avalon Trust held its Novo Nordisk (NVO) position steady in Q1 2026 at 2,000 shares worth $73.5K. The position accounts for 0.01% of the portfolio, ranked #244.

Avalon Trust first reported a position in NVO in Q1 2023 and has held it in 13 quarters since. The position peaked at $339K in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Avalon Trust held 2,000 shares of Novo Nordisk worth $73.5K as of Q1 2026.
Avalon Trust left its Novo Nordisk share count unchanged in Q1 2026.
Novo Nordisk made up 0.01% of Avalon Trust's portfolio in Q1 2026, its #244 holding.
Avalon Trust first reported a position in Novo Nordisk in Q1 2023 and has held it in 13 quarters since.
Avalon Trust's Novo Nordisk position peaked at $339K in Q2 2024.
1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Avalon Trust's 13F filing for Q1 2026, filed 6 May 2026.